Camurus AB logo

CAMX BTA - Camurus AB Share Price

SEK63.7 0.0  0.0%

Last Trade - 27/03/19

Sector
Healthcare
Size
Mid Cap
Market Cap £711.0m
Enterprise Value £693.8m
Revenue £17.9m
Position in Universe th / 1792
Bullish
Bearish
Unlock CAMX BTA Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
208.2 154.8 113.7 54.3 49.3 105.6 673.8 759.1 -12.7%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Camurus AB revenues increased from SEK30.4M to SEK130.2M. Net loss decreased 48% to SEK81.5M. Revenues reflect Sales of development related goods and services segment increase from SEK22.3M to SEK48.6M, Europe Union segment increase from SEK20.1M to SEK79.8M, Asia including Oceania segment increase from SEK7.6M to SEK42.2M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CAMX BTA Revenue Unlock CAMX BTA Revenue

Net Income

CAMX BTA Net Income Unlock CAMX BTA Revenue

Normalised EPS

CAMX BTA Normalised EPS Unlock CAMX BTA Revenue

PE Ratio Range

CAMX BTA PE Ratio Range Unlock CAMX BTA Revenue

Dividend Yield Range

CAMX BTA Dividend Yield Range Unlock CAMX BTA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CAMX BTA EPS Forecasts Unlock CAMX BTA Revenue
Profile Summary

Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a diversified research portfolio, which includes five products in clinical trials, and a number of additional product candidates in the pre-clinical phase. The Company’s product pipeline represents a mix of in-house and partnered projects in different development phases. Camurus AB is the parent company of the Group, which comprises four legal entities, namely Camurus Inc, Cubosome Inc, Camurus Development AB and Bioimplant Scandinavia AB.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since December 3, 2015
No. of Shareholders: n/a
No. of Employees: 132
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OMX Nordic Exchange Stockholm (Dual Listing)
Shares in Issue 51,636,858
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CAMX BTA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CAMX BTA
Upcoming Events for CAMX BTA
Frequently Asked Questions for Camurus AB
What is the Camurus AB share price?

As of 27/03/19, shares in Camurus AB are trading at SEK63.7, giving the company a market capitalisation of £711.0m. This share price information is delayed by 15 minutes.

How has the Camurus AB share price performed this year?

Shares in Camurus AB are currently trading at SEK63.7 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Camurus AB price has moved by % over the past year.

What are the analyst and broker recommendations for Camurus AB?

There are no analysts currently covering Camurus AB.

When will Camurus AB next release its financial results?

Camurus AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Camurus AB dividend yield?

Camurus AB does not currently pay a dividend.

Does Camurus AB pay a dividend?

Camurus AB does not currently pay a dividend.

When does Camurus AB next pay dividends?

Camurus AB does not currently pay a dividend.

How do I buy Camurus AB shares?

To buy shares in Camurus AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Camurus AB?

Shares in Camurus AB are currently trading at SEK63.7, giving the company a market capitalisation of £711.0m.

Where are Camurus AB shares listed? Where are Camurus AB shares listed?

Here are the trading details for Camurus AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: CAMX BTA
What kind of share is Camurus AB?

We were not able to load our ranking data for Camurus AB

Is there a Camurus AB share price forecast 2020?

We were not able to load any forecast data for Camurus AB.

How can I tell whether the Camurus AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Camurus AB. Over the past six months, the relative strength of its shares against the market has been %. At the current price of SEK63.7, shares in Camurus AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Camurus AB PE Ratio?

We were not able to find PE ratio data for Camurus AB.

Who are the key directors of Camurus AB?

Camurus AB's management team is headed by:

Fredrik Tiberg - PRE
Fredrik Joabsson - VBD
Markus Johnsson - VPR
Margareta Linden - VPR
Torsten Malmstrom - CTO
Rein Piir - VPR
Eva Pinotti-Lindqvist - CFO
Agneta Svedberg - VPR
Per Wallstrom - CHM
Per-Anders Abrahamsson - IND
Marianne Dicander Alexandersson - IND
Martin Jonsson - IND
Richard Jameson - OTH
Behshad Sheldon - IND
Mark Never - IND
Cecilia Callmer - VPR
Urban Paulsson - VPR
Annette Mattsson - VPR
Who are the major shareholders of Camurus AB?

Here are the top five shareholders of Camurus AB based on the size of their shareholding:

Similar to CAMX BTA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.